Clinical trial
A Multicenter, Observational Study of the Long-term Safety of Infliximab (REMICADE) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD). RESULTS COPD: REMICADE Safety Under Long Term Study in COPD
NCT00380796 is registered in ClinicalTrials.gov with Centocor, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Observational Study of the Long-term Safety of Infliximab (REMICADE) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD). RESULTS COPD: REMICADE Safety Under Long Term Study in COPD
- Lead sponsor
- Centocor, Inc.
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 30, 2006
- Completion date
- December 31, 2009
- Enrollment
- 88 (actual)
- Sites
- 26
Conditions
As the registry lists them; a condition with its own page is linked.